Thus, our current finding confirms our observation that Notch1 is a stronger tumor suppressor than Notch2 in a PDGF-driven mouse model of glioma [20] and implies that Notch1 could partially compensate for Notch2 loss. The gene discussed is NOTCH1; the disease is glioma.